BPG is committed to discovery and dissemination of knowledge
Number of total visits
33014187
Number of visits today
1592
Number of downloads
16204979
MEMBERSHIP
Cited by in F6Publishing
For:
Yang J , Zhou Y , Ban Y , Mi J , He Y , Li X , Liu Z , Wang K , Zhu G , Liu W , Tan Z , Sang Z . Development of naringenin-O -alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem 2022;37 :792-816. [PMID: 35193434 DOI: 10.1080/14756366.2022.2041627 ] [ Cited by in Crossref: 2] [ Cited by in F6Publishing: 2 ] [ Article Influence: 2.0 ] [ Reference Citation Analysis ]
Number
Citing Articles
1
Goyal A , Verma A , Dubey N , Raghav J , Agrawal A . Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease. J Food Biochem 2022;46 :e14415. [PMID: 36106706 DOI: 10.1111/jfbc.14415 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
2
Wu J , Zhang H, Wang Y, Yin G, Li Q, Zhuo L, Chen H, Wang Z. From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disorders. Front Pharmacol 2022;13 . [DOI: 10.3389/fphar.2022.1036030 ] [ Reference Citation Analysis ]
3
Zhang H , Peng Y , Zhuo L , Wang Y , Zeng G , Wang S , Long L , Li X , Wang Z . Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. Eur J Med Chem 2022;242 :114695. [PMID: 36044812 DOI: 10.1016/j.ejmech.2022.114695 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 1.0 ] [ Reference Citation Analysis ]
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA California Corporate Number: 3537345
